Celularity (CELU) Revenue (2020 - 2025)
Celularity (CELU) posted quarterly Revenue of $4.1 million for Q4 2025, up 496.51% year-over-year from $688000.0 in Q4 2024, and down 22.33% quarter-over-quarter from $5.3 million in Q3 2025.
Celularity (CELU) Revenue (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported Revenue for 6 consecutive years, with $4.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Revenue rose 496.51% year-over-year to $4.1 million; the TTM figure through Dec 2025 stood at $26.6 million (down 27.81% YoY), while the FY2025 annual figure was $26.6 million, down 51.03% from the prior year.
- Revenue slipped to $4.1 million in Q4 2025 per CELU's latest filing, from $5.3 million in the prior quarter.
- Across five years, Revenue topped out at $14.7 million in Q1 2024 and bottomed at $688000.0 in Q4 2024.
- Historically, Revenue has averaged $6.3 million across 5 years, with a median of $4.5 million in 2021.
- Annual changes were most pronounced in 2024 — Revenue tumbled 94.32% — and 2025, when it surged 496.51%.
- Celularity's Revenue stood at $4.9 million in 2021, then fell by 14.97% to $4.1 million in 2022, then surged by 193.34% to $12.1 million in 2023, then sank by 94.32% to $688000.0 in 2024, then soared by 496.51% to $4.1 million in 2025.
- Business Quant data shows CELU's Revenue at $4.1 million in Q4 2025, $5.3 million in Q3 2025, and $5.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Celularity | 20.90 Mn | 14.72 Mn | -3.27 Mn | 4.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.10 Mn |
| Sep 30, 2025 | 5.28 Mn |
| Jun 30, 2025 | 5.74 Mn |
| Mar 31, 2025 | 11.43 Mn |
| Dec 31, 2024 | 688,000.00 |
| Sep 30, 2024 | 9.30 Mn |
| Jun 30, 2024 | 12.11 Mn |
| Mar 31, 2024 | 14.68 Mn |
| Dec 31, 2023 | 12.11 Mn |
| Sep 30, 2023 | 3.79 Mn |
| Jun 30, 2023 | 2.94 Mn |
| Mar 31, 2023 | 3.94 Mn |
| Dec 31, 2022 | 4.13 Mn |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 3.78 Mn |
| Mar 31, 2022 | 5.94 Mn |
| Dec 31, 2021 | 4.86 Mn |
| Sep 30, 2021 | 10.62 Mn |
| Jun 30, 2021 | 3.20 Mn |
| Mar 31, 2021 | 2.66 Mn |